Literature DB >> 22491814

(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.

Chao Chen1, Hui Qiu, Jian Gong, Qing Liu, Han Xiao, Xin-Wen Chen, Bin-Lian Sun, Rong-Ge Yang.   

Abstract

(-)-Epigallocatechin-3-gallate (EGCG) is the most abundant catechin in green tea. In this study, we found that hepatitis C virus (HCV) infection was significantly suppressed by EGCG in an HCV cell culture (HCVcc) system using a JFH1-GFP chimeric virus, with a 50 % effective concentration (EC(50)) of 17.9 μM. The inhibitory activity of EGCG was confirmed by monitoring HCV RNA and protein expression levels in Huh7.5.1 cells infected with the JFH1 virus. Moreover, we demonstrated that the inhibitory mechanisms of EGCG were attributable to the suppression of both the HCV entry and RNA replication steps, although EGCG had little effect on translation directed by the viral internal ribosome entry site (IRES). Furthermore, HCV could be rapidly eliminated from cell cultures after two and five passages in the presence of 50 and 25 μM EGCG, respectively. These results indicate that EGCG is a potential candidate as a preventive and antiviral drug for HCV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491814     DOI: 10.1007/s00705-012-1304-0

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

1.  Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action.

Authors:  Noémie Calland; Marie-Emmanuelle Sahuc; Sandrine Belouzard; Véronique Pène; Pierre Bonnafous; Ahmed Atef Mesalam; Gaspard Deloison; Véronique Descamps; Sevser Sahpaz; Czeslaw Wychowski; Olivier Lambert; Priscille Brodin; Gilles Duverlie; Philip Meuleman; Arielle R Rosenberg; Jean Dubuisson; Yves Rouillé; Karin Séron
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

2.  Tale of Viruses in Male Infertility.

Authors:  Shreya Das; Arunima Mondal; Jayeeta Samanta; Santanu Chakraborty; Arunima Sengupta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Pan-genotypic Hepatitis C Virus Inhibition by Natural Products Derived from the Wild Egyptian Artichoke.

Authors:  Mahmoud Fahmi Elsebai; George Koutsoudakis; Verónica Saludes; Gemma Pérez-Vilaró; Ari Turpeinen; Sampo Mattila; Anna Maria Pirttilä; Fabien Fontaine-Vive; Mohamed Mehiri; Andreas Meyerhans; Juana Diez
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

Review 4.  Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.

Authors:  J Steinmann; J Buer; T Pietschmann; E Steinmann
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 5.  Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties.

Authors:  Laura Marín; Elisa M Miguélez; Claudio J Villar; Felipe Lombó
Journal:  Biomed Res Int       Date:  2015-02-23       Impact factor: 3.411

6.  Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro.

Authors:  Borris R T Galani; Marie-Emmanuelle Sahuc; Frederic N Njayou; Gaspard Deloison; Pierre Mkounga; William F Feudjou; Priscille Brodin; Yves Rouillé; Augustin E Nkengfack; Paul Fewou Moundipa; Karin Séron
Journal:  Front Microbiol       Date:  2015-05-15       Impact factor: 5.640

Review 7.  Antiviral Activity Exerted by Natural Products against Human Viruses.

Authors:  Maria Musarra-Pizzo; Rosamaria Pennisi; Ichrak Ben-Amor; Giuseppina Mandalari; Maria Teresa Sciortino
Journal:  Viruses       Date:  2021-05-04       Impact factor: 5.048

Review 8.  Hepatitis C virus and natural compounds: a new antiviral approach?

Authors:  Noémie Calland; Jean Dubuisson; Yves Rouillé; Karin Séron
Journal:  Viruses       Date:  2012-10-17       Impact factor: 5.048

9.  Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-induced inflammation.

Authors:  Ying-Ting Lin; Yu-Hsuan Wu; Chin-Kai Tseng; Chun-Kuang Lin; Wei-Chun Chen; Yao-Chin Hsu; Jin-Ching Lee
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

10.  In silico studies of medicinal compounds against hepatitis C capsid protein from north India.

Authors:  Shilu Mathew; Muhammad Faheem; Govindaraju Archunan; Muhammad Ilyas; Nargis Begum; Syed Jahangir; Ishtiaq Qadri; Mohammad Al Qahtani; Shiny Mathew
Journal:  Bioinform Biol Insights       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.